Search research articles
Contact Us
Filters
Showing results (161-170 of 167) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 167 results.
Frontiers in Immunology
|
May 22, 2020
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, et al.
Andrology
|
May 25, 2026
Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XR
Mohamad M Saab, Josephine Hegarty, Jack P Gleeson, et al.
Nature Medicine
|
October 17, 2022
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
Jesper D Gunst, Marie H Pahus, Miriam Rosás-Umbert, et al.
Nature Medicine
|
September 11, 2023
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
Jesper D Gunst, Jesper F Højen, Marie H Pahus, et al.
Nature Immunology
|
March 3, 2026
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control
Katie Fisher, Mauro A Garcia, Giacomo S Frattari, et al.
JAMA
|
July 12, 2022
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial
David W Oslin, Kevin G Lynch, Mei-Chiung Shih, et al.
Frontiers in Digital Health
|
October 15, 2025
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions
Emilia Daghir-Wojtkowiak, Javier Alfaro, Michele Mastromattei, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 167) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 167 results.
Frontiers in Immunology
|
May 22, 2020
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, et al.
Andrology
|
May 25, 2026
Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XR
Mohamad M Saab, Josephine Hegarty, Jack P Gleeson, et al.
Nature Medicine
|
October 17, 2022
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
Jesper D Gunst, Marie H Pahus, Miriam Rosás-Umbert, et al.
Nature Medicine
|
September 11, 2023
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
Jesper D Gunst, Jesper F Højen, Marie H Pahus, et al.
Nature Immunology
|
March 3, 2026
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control
Katie Fisher, Mauro A Garcia, Giacomo S Frattari, et al.
JAMA
|
July 12, 2022
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial
David W Oslin, Kevin G Lynch, Mei-Chiung Shih, et al.
Frontiers in Digital Health
|
October 15, 2025
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions
Emilia Daghir-Wojtkowiak, Javier Alfaro, Michele Mastromattei, et al.
Page
of 17